Clinical Trial Update: Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation [Phase 3]

View source ↗

Summary

Phase 3 trial assessing KPI-121 for safety and efficacy in postsurgical ocular inflammation/infection completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Infections
• Ocular Inflammation
• Postoperative Ocular Inflammation

Drugs mentioned

• KPI-121

Snippet

Sponsor: Kala Pharmaceuticals, Inc. | Conditions: Ocular Infections, Irritations and Inflammations | Phase 3 | Status: COMPLETED | Results posted: 2020-12-22